High prevalence of blaCTX-M-1/IncI1/ST3 and bla CMY-2/IncI1/ST2 plasmids in healthy urban dogs in France

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 5358-5362

  Haenni, Marisa ^a   Saras, Estelle ^a   Métayer, Véronique ^a   Médaille, Christine ^b   Madec, Jean Yves ^a  

^a Lyon Laboratory   (France)

^b LABORATOIRE VÉBIOTEL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; APRAMYCIN; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; CEFALEXIN; CEFOXITIN; CEPHALOSPORINASE; CHLORAMPHENICOL; CLOXACILLIN; COLISTIN; ENROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; FLORFENICOL; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NETILMICIN; OFLOXACIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; AMPC BETA-LACTAMASES; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE TEM-3;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CONTROLLED STUDY; DOG; ESCHERICHIA COLI; FRANCE; GENE IDENTIFICATION; HETEROZYGOTE; KLEBSIELLA PNEUMONIAE; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEQUENCE ANALYSIS; ANIMAL; CHINA; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PREVALENCE; PROCEDURES;

ANIMALS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEPHALOSPORINASE; CHINA; DOGS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PARIS; PLASMIDS; PREVALENCE; SALMONELLA ENTERICA;

EID: 84906092000     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02545-14     Document Type: Article

References (35)

1. Coque TM, Baquero F, Canton R. 2008. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 13(47):pii=19044. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044.
2. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV.2001. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45:2716-2722. http://dx.doi.org/10.1128/AAC.45.10.2716-2722.2001. (Pubitemid 32906662)
3. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281. http://dx.doi.org/10.1093/jac/dkm464.
4. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S. 2010. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65:651-660. http://dx.doi.org/10.1093/jac/dkq004.
5. Carattoli A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238. http://dx.doi.org/10.1128/AAC.01707- 08.
6. Carattoli A. 2011. Plasmids in Gram negatives: molecular typing of resistance plasmids. Int. J. Med. Microbiol. 301:654-658. http://dx.doi.org/10. 1016/j.ijmm.2011.09.003.
7. Dierikx CM, van Duijkeren E, Schoormans AH, van Essen-Zandbergen A, Veldman K, Kant A, Huijsdens XW, van der Zwaluw K, Wagenaar JA, Mevius DJ. 2012. Occurrence and characteristics of extended-spectrum-beta-lactamase-and AmpC-producing clinical isolates derived from companion animals and horses. J. Antimicrob. Chemother. 67:1368-1374. http://dx.doi.org/10.1093/jac/dks049.
8. Grami R, Mansour W, Dahmen S, Mehri W, Haenni M, Aouni M, Madec JY. 2013. The blaCTX-M-1 IncI1/ST3 plasmid is dominant in chickens and pets in Tunisia. J. Antimicrob. Chemother. 68:2950-2952. http://dx.doi.org/10.1093/jac/dkt258.
9. Dahmen S, Haenni M, Chatre P, Madec JY. 2013. Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from pets in France. J. Antimicrob. Chemother. 68:2797-2801. http://dx.doi.org/10.1093/jac/dkt291.
10. Dahmen S, Haenni M, Madec JY. 2012. IncI1/ST3 plasmids contribute to the dissemination of the blaCTX-M-1 gene in Escherichia coli from several animal species in France. J. Antimicrob. Chemother. 67:3011-3012. http://dx.doi.org/10. 1093/jac/dks308.
11. Costa D, Poeta P, Saenz Y, Coelho AC, Matos M, Vinue L, Rodrigues J, Torres C. 2008. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. Vet. Microbiol. 127:97-105. http://dx.doi.org/10.1016/j.vetmic.2007.08.004. (Pubitemid 350267038)
12. Hordijk J, Schoormans A, Kwakernaak M, Duim B, Broens E, Dierikx C, Mevius D, Wagenaar JA. 2013. High prevalence of fecal carriage of extended spectrum beta-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs. Front. Microbiol. 4:242. http://dx.doi.org/10.3389/fmicb.2013.00242.
13. Carattoli A, Lovari S, Franco A, Cordaro G, Di Matteo P, Battisti A. 2005. Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob. Agents Chemother. 49:833-835. http://dx.doi.org/10.1128/AAC.49.2.833-835.2005. (Pubitemid 40175711)
14. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Philippon A, Arlet G. 2004. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48:1249-1255. http://dx.doi.org/10.1128/AAC.48.4.1249-1255.2004. (Pubitemid 38405479)
15. Dierikx C, van Essen-Zandbergen A, Veldman K, Smith H, Mevius D. 2010. Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet. Microbiol. 145:273-278. http://dx.doi.org/10.1016/j.vetmic.2010.03.019.
16. Lavollay M, Mamlouk K, Frank T, Akpabie A, Burghoffer B, Ben Redjeb S, Bercion R, Gautier V, Arlet G. 2006. Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob. Agents Chemother. 50:2433-2438. http://dx.doi.org/10.1128/ AAC.00150-06. (Pubitemid 43993183)
17. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. http://dx.doi.org/10.1016/j.mimet.2005.03.018. (Pubitemid 41597366)
18. Garcia-Fernandez A, Chiaretto G, Bertini A, Villa L, Fortini D, Ricci A, Carattoli A. 2008. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin. J. Antimicrob. Chemother. 61:1229-1233. http://dx.doi.org/10. 1093/jac/dkn131. (Pubitemid 351753586)
19. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65:2518-2529. http://dx.doi.org/10.1093/jac/dkq347.
20. Doumith M, Day MJ, Hope R, Wain J, Woodford N. 2012. Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J. Clin. Microbiol. 50:3108-3110. http://dx.doi.org/10. 1128/JCM.01468-12.
21. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppe E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277. http://dx.doi.org/10.1093/jac/dkp194.
22. Meyer E, Gastmeier P, Kola A, Schwab F. 2012. Pet animals and foreign travel are risk factors for colonisation with extended-spectrum beta-lactamase-producing Escherichia coli. Infection 40:685-687. http://dx.doi.org/10.1007/s15010-012-0324-8.
23. Stolle I, Prenger-Berninghoff E, Stamm I, Scheufen S, Hassdenteufel E, Guenther S, Bethe A, Pfeifer Y, Ewers C. 2013. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. J. Antimicrob. Chemother. 68:2802-2808. http://dx.doi.org/10.1093/jac/dkt259.
24. Shaheen BW, Nayak R, Foley SL, Kweon O, Deck J, Park M, Rafii F, Boothe DM. 2011. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States. Antimicrob. Agents Chemother. 55:5666-5675. http://dx.doi.org/10.1128/AAC.00656-11.
25. CTX-M extended-spectrum beta-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin. Microbiol. Infect. 16:1475-1481. http://dx.doi.org/10.1111/j.1469-0691. 2010.03127.x.
26. Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V. 2013. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J. Antimicrob. Chemother. 68:562-568. http://dx.doi.org/10.1093/jac/dks429.
27. Bortolaia V, Larsen J, Damborg P, Guardabassi L. 2011. Potential pathogenicity and host range of extended-spectrum beta-lactamase-producing Escherichia coli isolates from healthy poultry. Appl. Environ. Microbiol. 77:5830-5833. http://dx.doi.org/10.1128/AEM.02890-10.
28. Accogli M, Fortini D, Giufre M, Graziani C, Dolejska M, Carattoli A, Cerquetti M. 2013. IncI1 plasmids associated with the spread of CMY-2, CTX-M-1 and SHV-12 in Escherichia coli of animal and human origin. Clin. Microbiol. Infect. 19:E238-E240. http://dx.doi.org/10.1111/1469-0691.12128.
29. Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp EK, Pfaller MA, Doern GV. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob. Agents Chemother. 44:2777-2783. http://dx.doi.org/10.1128/AAC.44.10.2777-2783.2000.
30. Wedley AL, Maddox TW, Westgarth C, Coyne KP, Pinchbeck GL, Williams NJ, Dawson S. 2011. Prevalence of antimicrobial-resistant Escherichia coli in dogs in a cross-sectional, community-based study. Vet. Rec 168:354. http://dx.doi.org/10.1136/vr.d1540.
31. CMY-2-IncI1/ST65 plasmid and topoisomerase mutations. J. Antimicrob. Chemother., in press.
32. CMY-2 among clinical Escherichia coli isolates from humans and companion animals in the upper Midwestern USA. J. Antimicrob. Chemother. 69:1492-1496. http://dx.doi.org/10. 1093/jac/dku011.
33. Folster JP, Pecic G, Singh A, Duval B, Rickert R, Ayers S, Abbott J, McGlinchey B, Bauer-Turpin J, Haro J, Hise K, Zhao S, Fedorka-Cray PJ, Whichard J, McDermott PF. 2012. Characterization of extended-spectrum cephalosporin-resistant Salmonella enterica serovar Heidelberg isolated from food animals, retail meat, and humans in the United States 2009. Foodborne Pathog. Dis. 9:638-645. http://dx.doi.org/10.1089/fpd.2012.1130.
34. Dierikx C, van der Goot J, Fabri T, van Essen-Zandbergen A, Smith H, Mevius D. 2013. Extended-spectrum-beta-lactamase-and AmpC-beta-lactamase- producing Escherichia coli in Dutch broilers and broiler farmers. J. Antimicrob. Chemother. 68:60-67. http://dx.doi.org/10.1093/jac/dks349.
35. Damborg P, Gaustad IB, Olsen JE, Guardabassi L. 2011. Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin. Vet. Microbiol. 151:404-408. http://dx.doi.org/10.1016/j.vetmic.2011.03.015.